Wolfgang Miesbach: How SUMOylation Limits AAV Gene Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”Gene therapy: same vector, same dose — up to 20 times more transgene.
Vector delivers the gene — the hepatocyte determines how efficiently it works.
At ISTH 2026, Denise Sabatino presented data identifying SUMOylation — a common host post-translational modification — as a restriction factor for transgene expression in AAV-transduced cells.
The agent: TAK-981 (subasumstat), a clinical-stage SUMO-activating enzyme inhibitor.
- In vitro: up to approximately 20 times higher transgene expression, across all cell types and promoters tested
- In vivo: around 36 times, 90 times and 200 times luciferase at days 1, 2 and 3
- Vector copy number lower while transgene mRNA and protein higher — driven not by increased vector uptake but by de-repression within the transduced cell
- Therapeutic transgenes: around 4 times FVIII (haemophilia A) and ~2× FIX-Padua (haemophilia B), including dosing months after transduction
- Effect transient and repeatable — a pharmacologically tunable intervention
SUMO-mediated restriction is an underappreciated limitation of AAV gene therapy, independent of serotype, promoter and transgene.
Modulating it may improve the durability and efficacy of expression — a relevant target for a field focused on long-term, predictable transgene output.”
Stay updated with Hemostasis Today.
-
Jul 22, 2026, 20:51Anu Thomas: ET vs IUT – Two Life-Saving Procedures, Different Stages of Care
-
Jul 22, 2026, 20:50Javed Anees: When and Whether to Restart a DOAC after Spontaneous ICH
-
Jul 22, 2026, 20:49Gerard J. Myers: Why Do Clinicians Ignore The Potential Morbidity Associated With IV Air and The Effects of VAE?
-
Jul 22, 2026, 20:47Phillip Smith: The Woman Who Was Told She Couldn’t Have Hemophilia
-
Jul 22, 2026, 20:45David McIntosh: Artificial Blood Will Require More Blood Donation, Not Less
-
Jul 22, 2026, 20:04Maria Cherska: Why Female Vascular Biology Matters for Precision Cardiometabolic Medicine
-
Jul 22, 2026, 19:27Alexandra Yakusheva: Stepping Into Senior Authorship – Our New Paper is Out!
-
Jul 22, 2026, 18:31Clivaz Léa: Presenting Research on Pregnancy-Related Pulmonary Embolism at ISTH 2026
-
Jul 22, 2026, 18:18Mohammed Alo: Arteries And Veins Are Structurally Built For Different Jobs